Antibodies against interleukin-1 receptor and uses thereof

Details for Australian Patent Application No. 2004270390 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Eugui, Elsie; Schumacher, Ralf; Bartke, Ilse; Fertig, Georg; Chizzonite, Anthony; Lanzendoerfer, Martin; Carr, Francis; Rueger, Petra; Truitt, Theresa; Hamilton, Anita

Agent Davies Collison Cave

Pub. Number AU-A-2004270390

PCT Pub. Number WO2005/023872

Priority 60/501,681 10.09.03 US; 03029659.4 23.12.03 EP

Filing date 9 September 2004

Wipo publication date 17 March 2005

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/023872 Priority application(s): WO2005/023872

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270394-Heterobicyclic compounds as pharmaceutically active agents

2004270389-Force-introduction point in core composites and method for producing said point using reinforcement elements that traverse the thickness of the core composite